PL2230932T3 - Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym - Google Patents
Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubymInfo
- Publication number
- PL2230932T3 PL2230932T3 PL08708546T PL08708546T PL2230932T3 PL 2230932 T3 PL2230932 T3 PL 2230932T3 PL 08708546 T PL08708546 T PL 08708546T PL 08708546 T PL08708546 T PL 08708546T PL 2230932 T3 PL2230932 T3 PL 2230932T3
- Authority
- PL
- Poland
- Prior art keywords
- colon
- active substance
- substance release
- coated pharmaceutical
- enhanced active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
- A23L27/72—Encapsulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN95CH2008 | 2008-01-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2230932T3 true PL2230932T3 (pl) | 2017-09-29 |
Family
ID=39798120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08708546T PL2230932T3 (pl) | 2008-01-10 | 2008-02-01 | Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9237760B2 (pl) |
| EP (1) | EP2230932B1 (pl) |
| JP (1) | JP5409651B2 (pl) |
| KR (1) | KR101500792B1 (pl) |
| CN (1) | CN101877971A (pl) |
| BR (1) | BRPI0822026B8 (pl) |
| CA (1) | CA2711473C (pl) |
| ES (1) | ES2626078T3 (pl) |
| HU (1) | HUE034848T2 (pl) |
| IL (1) | IL205488A (pl) |
| MX (1) | MX2010007577A (pl) |
| PL (1) | PL2230932T3 (pl) |
| SI (1) | SI2230932T1 (pl) |
| WO (1) | WO2009086940A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2759626T3 (es) * | 2007-05-07 | 2020-05-11 | Evonik Operations Gmbh | Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco |
| WO2013144176A1 (en) * | 2012-03-30 | 2013-10-03 | Laboratorios Del Dr. Esteve, S.A. | Controlled release formulatin comprising mesalamine |
| US20140141075A1 (en) | 2012-11-21 | 2014-05-22 | Warner Chilcott Company, Llc | 5-aminosalicylic acid capsule formulation |
| US11229600B2 (en) * | 2014-09-24 | 2022-01-25 | Vital Beverages Global Inc. | Compositions and methods for selective GI tract delivery |
| MX2017006200A (es) | 2014-11-14 | 2017-11-17 | Gemphire Therapeutics Inc | Procesos e intermediarios para preparar dialcano eteres terminados con acido a, ?-dicarboxilico. |
| BR112017025148A2 (pt) | 2015-06-05 | 2018-08-07 | Evonik Röhm Gmbh | composição farmacêutica ou nutracêutica com resistência contra a influência do etanol |
| JP6955648B2 (ja) | 2015-09-01 | 2021-10-27 | ファースト ウェーブ バイオ インコーポレイテッド | 異常炎症反応に関連する状態を処置するための方法および組成物 |
| US10588864B2 (en) | 2016-03-11 | 2020-03-17 | Gateway Pharmaceuticals LLC | Pharmaceutical compositions for colon-specific delivery |
| US20190111001A1 (en) * | 2016-03-30 | 2019-04-18 | University Of Maryland, Baltimore | Microparticulate system for colonic drug delivery |
| US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
| TW201906599A (zh) * | 2017-05-11 | 2019-02-16 | 美商珍費爾醫療公司 | 吉卡賓組成物及其使用方法 |
| JP7336187B2 (ja) * | 2017-11-30 | 2023-08-31 | 日本ケミファ株式会社 | 多層構造を有する粒子状医薬組成物 |
| KR20220113698A (ko) | 2019-12-11 | 2022-08-16 | 에보닉 오퍼레이션스 게엠베하 | 질환을 치료 또는 예방하는데 사용하기 위한 투여 형태 |
| WO2021142238A1 (en) | 2020-01-10 | 2021-07-15 | First Wave Bio, Inc. | Deuterated niclosamide |
| WO2021188564A1 (en) | 2020-03-16 | 2021-09-23 | First Wave Bio, Inc. | Methods of treating covid-19 with a niclosamide compound |
| US10980756B1 (en) | 2020-03-16 | 2021-04-20 | First Wave Bio, Inc. | Methods of treatment |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE64726B1 (en) * | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| FR2759293B1 (fr) | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
| DE19845358A1 (de) | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
| DE10013029A1 (de) | 2000-03-17 | 2001-09-20 | Roehm Gmbh | Mehrschichtige Arzneiform für die Colonfreigabe |
| DE10149674A1 (de) | 2001-10-09 | 2003-04-24 | Apogepha Arzneimittel Gmbh | Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung |
| DE10250543A1 (de) | 2002-10-29 | 2004-05-19 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform |
| MXPA04010956A (es) | 2003-01-30 | 2005-01-25 | Roehm Gmbh | Forma de dosis farmaceutica y metodo para la produccion de la misma. |
| DE10353196A1 (de) | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform mit einer die Abgabe einer modulatorischen Substanz beeinflussenden Matrix |
| DE10353186A1 (de) | 2003-11-13 | 2005-06-16 | Röhm GmbH & Co. KG | Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz |
| GB0403098D0 (en) | 2004-02-12 | 2004-03-17 | Euro Celtique Sa | Extrusion |
| CN101484147B (zh) | 2006-08-18 | 2015-07-08 | 赢创罗姆有限责任公司 | 对于具有水中良好溶解性的活性成分具有受控的活性成分释放性的药物组合物 |
| DE102007009243A1 (de) | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets mit einer Wirkstoff-Matrix und einem Polymerüberzug, sowie ein Verfahren zur Herstellung der Pellets |
| ES2759626T3 (es) | 2007-05-07 | 2020-05-11 | Evonik Operations Gmbh | Formas farmacéuticas sólidas que comprenden un recubrimiento entérico con liberación acelerada del fármaco |
-
2008
- 2008-02-01 SI SI200831827A patent/SI2230932T1/sl unknown
- 2008-02-01 CA CA2711473A patent/CA2711473C/en active Active
- 2008-02-01 BR BRPI0822026A patent/BRPI0822026B8/pt active IP Right Grant
- 2008-02-01 US US12/742,842 patent/US9237760B2/en active Active
- 2008-02-01 MX MX2010007577A patent/MX2010007577A/es active IP Right Grant
- 2008-02-01 PL PL08708546T patent/PL2230932T3/pl unknown
- 2008-02-01 HU HUE08708546A patent/HUE034848T2/en unknown
- 2008-02-01 CN CN2008801181774A patent/CN101877971A/zh active Pending
- 2008-02-01 ES ES08708546.0T patent/ES2626078T3/es active Active
- 2008-02-01 WO PCT/EP2008/051236 patent/WO2009086940A1/en active Application Filing
- 2008-02-01 JP JP2010541717A patent/JP5409651B2/ja active Active
- 2008-02-01 KR KR1020107015181A patent/KR101500792B1/ko active IP Right Grant
- 2008-02-01 EP EP08708546.0A patent/EP2230932B1/en active Active
-
2010
- 2010-05-02 IL IL205488A patent/IL205488A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2711473A1 (en) | 2009-07-16 |
| EP2230932A1 (en) | 2010-09-29 |
| JP5409651B2 (ja) | 2014-02-05 |
| BRPI0822026A2 (pt) | 2014-10-07 |
| KR20100103566A (ko) | 2010-09-27 |
| MX2010007577A (es) | 2010-08-04 |
| JP2011509264A (ja) | 2011-03-24 |
| WO2009086940A1 (en) | 2009-07-16 |
| US9237760B2 (en) | 2016-01-19 |
| US20100247639A1 (en) | 2010-09-30 |
| HUE034848T2 (en) | 2018-03-28 |
| BRPI0822026B8 (pt) | 2021-05-25 |
| IL205488A (en) | 2016-08-31 |
| CA2711473C (en) | 2016-01-26 |
| BRPI0822026B1 (pt) | 2019-05-07 |
| ES2626078T3 (es) | 2017-07-21 |
| SI2230932T1 (sl) | 2017-07-31 |
| KR101500792B1 (ko) | 2015-03-09 |
| IL205488A0 (en) | 2010-12-30 |
| CN101877971A (zh) | 2010-11-03 |
| EP2230932B1 (en) | 2017-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2230932T3 (pl) | Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym | |
| IL275854A (en) | Pharmaceutical composition and its administration | |
| ZA201101477B (en) | Co-crystals and pharmaceutical formulations comprising the same | |
| IL212339A (en) | Pyrolobenzodiazepine derivatives and processes for their preparation | |
| HK1158528A1 (zh) | 藥物製劑 | |
| IL211400A0 (en) | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof | |
| IL209419A0 (en) | Modified drugs for use in liposomal nanoparticles | |
| ZA201104348B (en) | Pharmaceutical preparation | |
| PL2402035T3 (pl) | Materiał powlekający do stałego preparatu farmaceutycznego i stały preparat farmaceutyczny utworzony z jego użyciem | |
| HK1162936A1 (en) | Solid pharmaceutical formulation with delayed release | |
| HU0800591D0 (en) | Stable pharmaceutical combination | |
| GB0815972D0 (en) | Pharmaceutical preparation | |
| EP2208732A4 (en) | DEHYDROXYLATED VANCOMYCIN, PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
| EP2306998A4 (en) | PHARMACEUTICAL FORMULATION | |
| ZA201104710B (en) | Pharmaceutical dispenser and use thereof | |
| IL212603A0 (en) | Combined drug administration | |
| IL208788A (en) | Pharmacy-based formulation | |
| IL205550A0 (en) | Coated pharmaceutical or nutraceutical preparation with enhanced pulsed active substance release | |
| IL205492A0 (en) | Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release | |
| EP2363132A4 (en) | USE OF SOPHORICOSIDE IN DRUG MANUFACTURE | |
| EP2309856A4 (en) | PHARMACEUTICAL COMPOUNDS AS CYTOTOXICA AND ITS APPLICATION | |
| EP2275437A4 (en) | POLYPEPTIDE AND PHARMACEUTICAL COMPOSITION CONTAINING THE POLYPEPTIDE | |
| PL378648A1 (pl) | Preparat farmaceutyczny oraz sposób jego otrzymywania | |
| GB0811599D0 (en) | Improvements in anticancer drugs | |
| PL381879A1 (pl) | Postać preparatu farmaceutycznego oraz sposób jej otrzymywania |